Exogenous administration of bone marrow-derived stem cells in experimental COPD

B. Lobo, R. Puig-Pey, E. Ferrer, D. Domínguez-Fandos, N. Coll, J. García, C. Bonjoch, J. A. Barberà, V. I. Peinado (Barcelona, Spain)

Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways
Session: Cutting edge: drug delivery to the airways
Session type: Oral Presentation
Number: 225
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Lobo, R. Puig-Pey, E. Ferrer, D. Domínguez-Fandos, N. Coll, J. García, C. Bonjoch, J. A. Barberà, V. I. Peinado (Barcelona, Spain). Exogenous administration of bone marrow-derived stem cells in experimental COPD. Eur Respir J 2013; 42: Suppl. 57, 225

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pretreatment of human adipose derived mesenchymal stem cells with PPAR-γ agonist improved effects of regeneration in elastase induced emphysema mouse model
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015

Bone marrow-derived mesenchymal stem cells transplantation in a model of bronchiolitis obliterans
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

Both intranasal and intraperitoneal administration of human tubal mesenchymal stem cells (htMSC) ameliorates experimental COPD model
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014

Bone marrow-derived MSCs from patients with COPD have abnormal functional capacity
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013

Intratracheal administration of bone marrow-derived mesenchymal stem cells ameliorates lung function
Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Year: 2016


LSC 2010 Abstract: Does cigarette smoking influence bone marrow microenvironment? Down-regulation of CXCR4 expression in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): preliminary results
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010

Effect of low level laser (LLL) and mesenchymal stem cells (htMSCs) therapies on cigarette-induced lung inflammation in mice
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013

Impaired migration of bone marrow mesenchymal stem cells in COPD
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013


Immunotherapeutic strategy with mesenchymal stem cells modulating inflammation in an experimental model of COPD.
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020

In vivo chracterization of bone marrow derived progenitor cells in airway remodeling in murine asthma model
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007


Adipose derived stem cells ameliorate airway inflammation in mouse models of asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015


Late-breaking abstract: Comparison of bone marrow derived-mononuclear cells with mesenchymal stem cells on inflammatory and remodeling processes in experimental chronic allergic asthma
Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New mechanisms in airway disease
Year: 2011

Increased expression of TERT mRNA expresssion in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): Preliminary results
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010

Functional comparison of bone-marrow derived mesenchymal stromal cells obtained from COPD patients and non-COPD controls
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015


Effect of mast cells degranulation blockade on the inflammatory response outcome in the COPD model
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016


Synergistic effect of human tubal mesenchymal stem cell (htMSCs) and low level laser (LLL) therapy significantly reduces experimental COPD in mice
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014

The effect of allergen-pulsed bone marrow-derived dendritic cells in mouse asthma model depends on the injection time
Source: Annual Congress 2004 - Animal models of allergic airway disease
Year: 2004


Effect of intratracheal transplantation of bone marrow-derived endothelial progenitor cell on cigarette smoking-induced emphysema in mice
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010

Allergen-pulsed bone marrow-derived dendritic cells abolish the influx of allergic inflammatory cells in mouse asthma model
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015